| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |